Concepedia

Midori Hoshizaki

MH

6

Publications

218

Citations

6

H-Index

2018

Active since

Affiliations

National Institute of Biomedical Innovation, Health and Nutrition(Current)

Akita University

University of British Columbia

Institute of Molecular Biotechnology

Japan International Research Center for Agricultural Sciences

Midori Hoshizaki is an author at National Institute of Biomedical Innovation, Health and Nutrition specializing in medicine, immunology, and tumor biology.

Top concepts

Publications per year

2018–2022

6

Publications

6

B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction

Takafumi Minato, Satoru Nirasawa, Teruki Sato et al. · Nature Communications · 2020 · 60 citations · Full text

, , +20

m<sup>6</sup>A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis

Yushi Nagaki, Satoru Motoyama, Tomokazu Yamaguchi et al. · Genes to Cells · 2020 · 56 citations · Full text

ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury

Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato et al. · Nature Communications · 2021 · 54 citations · Full text

Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection

S Fujiwara, Midori Hoshizaki, Yu Ichida et al. · Nature Microbiology · 2018 · 23 citations

, , +4

ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury

Takafumi Minato, Tomokazu Yamaguchi, Midori Hoshizaki et al. · PLoS ONE · 2022 · 13 citations · Full text

Rows per page

1–5 of 6